In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 1, 1997, Pages 53-61

  Gould, I M ^a   Milne, K ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; TAZOBACTAM;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CITROBACTER; DRUG POTENTIATION; ENTEROBACTER; ENTEROCOCCUS FAECALIS; NONHUMAN; PHARMACODYNAMICS; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BETA-LACTAMASES; CIPROFLOXACIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; GENTAMICINS; KINETICS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN;

EID: 0031050317     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.1.53     Document Type: Article

References (20)

1. Anderson, E. T., Young, L. S. & Hewitt, W. L. (1978). Antimicrobial synergism in the therapy of Gram-negative rod bacteremia. Chemotherapy 24, 45-54.
2. Krogstad, D. J. & Moellering, R. C. (1986). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 2nd edn (Lorian, V., ed.), PP- 537-95. Williams & Wilkins, Baltimore, MD.
3. Klastersky, J., Cappel, R. & Daneau, D. (1972). Clinical significance of in vitro synergy between antibiotics and Gram-negative infections. Antimicrobial Agents and Chemotherapy 2, 470-5.
4. Klastersky, J., Daneau, D., Swings, G. & Weerts, D. (1974). Antibacterial activity in serum and urine as therapeutic guide in bacterial infections. Journal of Infectious Diseases 129, 187-93.
5. EORTC International Antimicrobial Therapy Project Group (1978). Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137, 14-29.
6. Chen, H. Y., Bonfiglio, G., Allen, M., Piper, D., Edwardson, T., McVey, D. et al. (1993). Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles. Journal of Antimicrobial Chemotherapy 32, 247-66.
7. Gould, I. M., Wilson, D., Milne, K., Paterson, A., Golder, D. & Russell, D. (1991). Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques. Antimicrobial Agents and Chemotherapy 35, 2407-9.
8. Working Party of the British Society for Antimicrobial Chemotherapy (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 4-9.
9. Bach, V. T., Webb, D. W. & Thadepalli, H. (1980). Antimicrobial synergy of piperacillin and gentamicin against Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis. Chemotherapy 26, 21-7.
10. Hoogkamp-Korstanje, J. A. A. & Westerdaal, N. A. (1982). Activity of synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa. Infection 10, Suppl. 3, S257- 61.
11. Drusano, G. L., Schimpff, S. C. & Hewitt, W. L. (1984). The acylampicillins: mezlocillin, piperacillin and azlocillin. Review of Infectious Diseases 6, 13-32.
12. Fursted, K. & Gerner-Smidt, P. (1987). Analysis of the interaction between piperacillin and ciprofloxacin or tobramycin against thirteen strains of Pseudomonas aeruginosa using kill curves. Acta Pathologica Microbiologica Scandinavica Section 695, 193-7.
13. Guerillot, F., Garret, G. & Flandrois, J. P. (1993). A statistical evaluation of the bactericidal effects of ceftibuten in combination with aminoglycosides and ciprofloxacin. Journal of Antimicrobial Chemotherapy 32, 685-94.
14. Kerr, J. R. (1993). In vitro activities of two drug combinations of ceftazidime, cefotaximer cefuroxime, ciprofloxacin, chloramphenicol, imipenem and temocillin against clinical isolates of Pseudomonas cepacia from patients with cystic fibrosis. International Journal of Antimicrobial Agents 3, 205-9.
15. Hyatt, J. M., Nix, D. E., Stratton, C. W. & Schentag, J. J. (1995). In vitro pharmacodynamics of piperacillin-tazobactam and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 39, 1711-6.
16. Wootton, M., Hedges, A. J., Bowker, K. E., Holt, H. A., Reeves, D. S. & MacGown, A. P. (1995). A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative β-lactam, amino- glycoside and fluoroquinolone. Journal of Antimicrobial Chemotherapy 35, 569-76.
17. Drugeon, H. B., Caillon, J., Juvin, M. E. & Pirault, J. L. (1987). Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve chequerboard method. Journal of Antimicrobial Chemotherapy 19, 197-203.
18. Modelling, R. C. (1979). Antimicrobial synergy-an elusive concept. Journal of Infectious Diseases 140, 639-41.
19. Norden, C. W., Wentzel, H. & Keleti, E. (1979). Comparison of techniques for measurement of in vitro antibiotic synergy. Journal of Infectious Diseases 140, 629-33.
20. Hallander, H. O., Dornbusch, K., Gezelius, L., Jacobson, K. & Karlsson, I. (1982). Synergy between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrobial Agents and Chemotherapy 22, 743-52.